Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   

GENE - CHEMICAL INTERACTIONS REPORT

RGD ID: 621315
Species: Rattus norvegicus
RGD Object: Gene
Symbol: Map1lc3b
Name: microtubule-associated protein 1 light chain 3 beta
Acc ID: CHEBI:6078
Term: ivermectin
Definition: A mixture consisting of >= 90% 22,23-dihydroavermectin B1a (R = Me) and <= 10% 22,23-dihydroavermectin B1b (R = H). A semi-synthetic derivative of abamectin, it is used as a broad-spectrum antiparasite medication, particularly against worms (except tapeworms), although it is also effective against most mites and some lice.
Chemical ID: MESH:D007559
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction is comprised of a complex set of reactions and/or regulatory events, possibly involving additional chemicals and/or gene products.
Object SymbolQualifierEvidenceWithReferenceSourceNotesOriginal Reference(s)
Map1lc3bdecreases expressionISOMAP1LC3B (Homo sapiens)6480464CTDIvermectin results in decreased expression of MAP1LC3B proteinPMID:32959892
Map1lc3bmultiple interactionsISOMAP1LC3B (Homo sapiens)6480464CTD3-methyladenine inhibits the reaction [Ivermectin results in increased expression of and results in increased lipidation of MAP1LC3B protein]; AZD 1480 inhibits the reaction [SLC2A4 protein inhibits the reaction [Ivermectin results in increased expression of and results in increased lipidation of MAP1LC3B protein]]; Glutathione inhibits the reaction [Ivermectin results in increased expression of and results in increased lipidation of MAP1LC3B protein]; Ivermectin results in increased expression of and results in increased lipidation of MAP1LC3B protein; SLC2A4 protein inhibits the reaction [Ivermectin results in increased expression of and results in increased lipidation of MAP1LC3B protein]PMID:34904774
Go Back to source page   Continue to Ontology report